Skip to main content

Advertisement

SpringerLink
Log in

Clinical pharmacists and basic scientists: do patients and physicians need this collaboration?

  • Commentary
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

The aim of this commentary is to highlight the vital and beneficial role that pharmacists and inter-professional collaborative practice play in patient care from the economic, humanistic, efficacy, and safety perspectives. Pharmacists, particularly those with an in-depth knowledge of the basic pharmaceutical sciences, recognize the need to collaborate with other healthcare professions and understand the importance of combining all of the components of their education into a well-rounded, comprehensive clinical practice. Indeed, there is ample evidence in the literature that pharmacists equipped with a solid foundation in basic pharmaceutical science, coupled with clinical knowledge and skills can, more effectively, contribute to pharmacotherapy and patient care, particularly in a collaborative practice setting. Consequently, the burden on pharmacy education is to maintain its emphasis on the basic sciences while promoting the application of these sciences in clinical practice, in the Pharm. D. curriculum. This is a goal that can also be achieved through inter-professional educational approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Slone Survey. Patterns of medication use in the United States 2005. 2010. http://web.bu.edu/slone/SloneSurvey/AnnuallyRpt/SloneSurveyWebReport2006.pdf. Accessed 20 Oct 2010.

  2. IMS Health Report, 2010. 1 Apr 2010.

  3. Truffer CJ, Keehan S, Smith S, Cylus J, et al. Health spending projections through 2019: the recession’s impact continues. Health Aff. 2010;29:522–9.

    Article  Google Scholar 

  4. World Health Organization 2000 Report. Health systems: improving performance. Geneva: World Health Organization. ISBN 92 4 156198 X.

  5. American Academy of Family Physicians, American Academy of Pediatrics, American College of Physicians, American Osteopathic Association. Joint principles of the patient centered medical home [Internet]. Philadelphia: ACP; 2007. http://www.medicalhomeinfo.org/joint%20Statement.pdf. Accessed 23 Oct 2010.

  6. National Committee for Quality Assurance [Internet]. Press release, NCQA program to evaluate patient-centered medical homes; PPC-PCMH to focus on care coordination, integration. Washington: NCQA; 2010. Available from: http://www.ncqa.org/tabid/641/Default.aspx?printFriendly=yes. 23 Oct 2010.

  7. Anaya JP, Rivera JO, Lawson K, Garcia J, et al. Evaluation of pharmacist managed diabetes mellitus under a collaborative drug therapy agreement. Am J Health Syst Pharm. 2008;65:1841–5.

    Article  PubMed  Google Scholar 

  8. Bjornson DC, Hiner WO Jr, Potyk RP, Nelson BA, et al. Effect of pharmacist on health care outcomes in hospitalized patients. Am J Hosp Pharm. 1993;50:1875–84.

    PubMed  CAS  Google Scholar 

  9. Bond CA, Raehl Cl. Clinical and economic outcomes of pharmacist managed antimicrobial prophylaxis in surgical patients. Am J Health Syst Pharm. 2007;64:1935–42.

    Article  PubMed  Google Scholar 

  10. Boyko WL Jr, Yurkowski PJ, Ivey MF, Armitstead JA, et al. Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health Syst Pharm. 1997;45:1591–5.

    Google Scholar 

  11. Isetts BJ, Schondelmeyer SW, Artz MB, Lenarz LA, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc. 2008;48:203–11. 3p following 211.

    Article  Google Scholar 

  12. Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166:955–64.

    Article  PubMed  Google Scholar 

  13. Ponniah A, Anderson B, Shabkib S, Doecke CJ, et al. Pharmacists’ role in the post-discharge management of patients with heart failure: a literature review. J Clin Pharm Ther. 2007;32:343–52.

    Article  PubMed  CAS  Google Scholar 

  14. Roughead L, Semple S, Vitry A. The value of pharmacist professional services in the community setting. A systematic review of the literature 1990–2002. 2010. http://beta.guild.org.au/uploadedfiles/Research_and_Development_Grants_Program/Projects/2002-507_fr.pdf. Accessed 10 Oct 2010.

  15. Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med. 2003;29:691–8.

    PubMed  Google Scholar 

  16. Singhal PK, Raisch DW, Gupchup GV. The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research. Ann Pharmacother. 1999;33:1336–55.

    Article  PubMed  CAS  Google Scholar 

  17. Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilization, costs and patient outcomes. Cochrane Database Syst. 2000; CD000336.

  18. Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med. 2003;25:144–53.

    Article  PubMed  Google Scholar 

  19. Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28:421–36.

    Article  PubMed  Google Scholar 

  20. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta analysis in diabetes management. Ann Pharmacother. 2007;41:1569–82.

    Article  PubMed  Google Scholar 

  21. Morrison A, Wertheimer AI. Evaluation of studies investigating the effectiveness of pharmacists’ clinical services. Am J Health Syst Pharm. 2001;58:569–77.

    PubMed  CAS  Google Scholar 

  22. Holland R, Desborough J, Goodyer L, Hall S, et al. Does pharmacist-led medication review help to reduce hospital admissions and death in older people? A systematic review and meta analysis. Br J Clin Pharmacol. 2008;65:303–16.

    Article  PubMed  Google Scholar 

  23. Pickard AS, Hung SY. An update on evidence of clinical pharmacy services’ impact on health-related quality of life. Ann Pharmacother. 2006;40:1623–34.

    Article  PubMed  Google Scholar 

  24. Machado M, Nassor N, Bajcar JM, Guzzo GC, et al. Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta analysis in hyperlipidemia management. Ann Pharmacother. 2008;42:1195–207.

    Article  PubMed  Google Scholar 

  25. Doucette WR, Witrlky MJ, Farrisk KB, McDonough RP. Community pharmacist-provided extended diabetes care. Ann Pharmacother. 2009;43:882–9.

    Article  PubMed  Google Scholar 

  26. McFarland MS, Cross LB, Gross B, Gentry C, et al. Drug use evaluation of Sitagliptin dosing by pharmacist versus non-pharmacist clinicians in an internal medicine department of a private physician-owned multispecialty clinic. J Manag Care Pharm. 2009;15:563–7.

    PubMed  Google Scholar 

  27. Taddei S, Bruno RM, Ghiadoni L. The correct administration of antihypertensive drugs according to the principles of clinical pharmacology. Am J Cardiovasc Drugs. 2011;11:13–20.

    Article  PubMed  CAS  Google Scholar 

  28. Machado M, Bajcar J, Guzzo GC, et al. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta analysis in hypertension management. Ann Pharmacother. 2007;41:1770–81.

    Article  PubMed  Google Scholar 

  29. Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28(4):421–6.

    Article  PubMed  Google Scholar 

  30. Iyer R, Coderre P, McKelvey T, Cooper J, et al. An employer-based, pharmacist intervention model for patients with type 2 diabetes. Am J Health Syst Pharm. 2010;67:312–6.

    Article  PubMed  Google Scholar 

  31. LaMarr B, Valdez C, Driscoll K, Ryan M. Influence of pharmacist intervention on prescribing of angiotensin-converting-enzyme inhibitors, angiotensin II-receptor blockers, and aspirin for diabetic patients. Am J Health Syst Pharm. 2010;67:290–4.

    Article  PubMed  Google Scholar 

  32. Planas LG, Crosby KM, Mitchell KD, Farmer KC. Evaluation of a hypertension medication therapy management program in patients with diabetes. J Am Pharm Assoc. 2009;49:164–70.

    Article  Google Scholar 

  33. Carter BL, Ardery G, Dawson JD, James PA, et al. Physician and Pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169:1996–2002.

    Article  PubMed  Google Scholar 

  34. Weber CA, Ernst ME, Sezate GS, Zheng S, et al. Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures. Arch Intern Med. 2010;170:1634–9.

    Article  PubMed  Google Scholar 

  35. Birtcher KK, Greisinger AJ, Brehm BJ, Wehmanen OA, et al. A secondary prevention lipid clinic reaches low-density lipoprotein cholesterol goals more often than usual cardiology care with coronary heart disease. J Clin Lipidol. 2010;4:46–52.

    Article  PubMed  Google Scholar 

  36. Rudd KM, Dier JG. Comparison of two different models of anticoagulation management services with usual medical care. Pharmacotherapy. 2010;30:330–8.

    Article  PubMed  Google Scholar 

  37. Simpson SH, Majumdar SR, Tsuyuki RT, Lewanczuk RZ, et al. Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial. Diabetes Care. 2011;34:20–6.

    Article  PubMed  Google Scholar 

  38. Bunting BA, Smith BH, Sutherland SE. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173–84.

    Article  Google Scholar 

  39. Smith M, Bates DW, Bodenheimer T, Cleary PD. Why pharmacists belong in the medical home. Health Aff. 2010;29:906–13.

    Article  Google Scholar 

  40. Ting HJ, Khasawneh FT. Glybenclamide: an antidiabetic with in vivo antithrombotic activity. Eur J Pharmacol. 2010;649:249–54.

    Article  PubMed  CAS  Google Scholar 

  41. Nunez A, Gomez J, Zalba LR, Monton M, et al. Losartan inhibits in vitro platelet activation: comparison with candesartan and valsartan. J Renin Angiotensin Aldosterone Syst. 2000;1:175–9.

    Article  PubMed  CAS  Google Scholar 

  42. Basaria S, Coviello AD, Travison TG, Storer TW, et al. Adverse events associated with testosterone administration. N Engl J Med. 2010;363:109–22.

    Article  PubMed  CAS  Google Scholar 

  43. Phillips GB. Adverse events associated with testosterone administration. N Engl J Med. 2010;363:1866.

    PubMed  Google Scholar 

  44. Chatterjee R, Yeh H-C, Shafi T. Serum and dietary potassium and risk of incident type 2 diabetes mellitus. Arch Intern Med. 2010;170:1745–51.

    Article  PubMed  CAS  Google Scholar 

  45. Sudano I, Flammer AJ, Périat D, Enseleit F, et al. Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation. 2010;122:1789–96.

    Article  PubMed  CAS  Google Scholar 

  46. Roche VF. The chemically elegant proton pump inhibitors. Am J Pharm Educ. 2006;70:101.

    Article  PubMed  Google Scholar 

  47. Newton DW. Science-based pharmacy education. Am J Pharm Educ. 2007;71:38.

    Article  PubMed  Google Scholar 

  48. Ryu KH, Han HY, Lee SY, Jeon SD, et al. Ginkgo biloba extract enhances antiplatelet and antithrombotic effects of cilostazol without prolongation of bleeding time. Thromb Res. 2009;124:328–34.

    Article  PubMed  CAS  Google Scholar 

  49. Mohamed ME, Frye RF. Effects of herbal supplements on drug glucuronidation. Review of clinical, animal, and in vitro studies. Planta Med; 2010 Nov 3 [ahead of print].

  50. Zhu H, Butera M, Nelson D, Liu C. Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication. Virol J. 2005;2:80.

    Article  PubMed  Google Scholar 

  51. Cavallari LH, Overholser BR, Anderson D, Boyce E, et al. Recommended basic science foundation necessary to prepare pharmacists to manage personalized pharmacotherapy. Pharmacotherapy. 2010;30:228e–35e.

    Article  Google Scholar 

  52. McNair PP. The case for educating health care students in professionalism as the core content of inter-professional education. Med Educ. 2005;39:456–64.

    Article  PubMed  Google Scholar 

  53. Chisholm-Burns MA, Lee JK, Spivey CA, Slack M, et al. US pharmacists effect as team members on patient care. Med Care. 2010;48:923–33.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Patricia Klotz, RN, and Dr. Wallace J. Murray for proofreading and editing the manuscript. The opinions, findings and conclusions herein are those of the author and not necessarily represent those The Regents of the University of California, or any of its programs.

Funding

This research was supported, in part, by funds provided by The Regents of the University of California, Tobacco-Related Disease Research Program, Grant Number 19KT-0030 (to F.T.K).

Conflicts of interests

None.

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, 309 E. 2nd Street, Pomona, CA, 91766, USA

    Amir H. Zargarzadeh & Fadi T. Khasawneh

  2. Department of Pharmacy Practice and Administration, College of Pharmacy, Western University of Health Sciences, 309 E. 2nd Street, Pomona, CA, 91766, USA

    Susan Jacob & Roger S. Klotz

Authors
  1. Amir H. Zargarzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susan Jacob
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roger S. Klotz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fadi T. Khasawneh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Roger S. Klotz or Fadi T. Khasawneh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zargarzadeh, A.H., Jacob, S., Klotz, R.S. et al. Clinical pharmacists and basic scientists: do patients and physicians need this collaboration?. Int J Clin Pharm 33, 886–894 (2011). https://doi.org/10.1007/s11096-011-9562-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-011-9562-6

Keywords

Search

Navigation